Table 2. Findings for other factors, treatment data and infectious keratopathy in the two patient groups and durations of hospitalization.
Groups | Cases | Smoking consumption habits |
Alcohol consumption habits |
Inducement |
Durations of hospitalization | Treatment |
Bacterial keratitis | Fungal keratitis | HSK | AK | ||||
Yes | No | Yes | No | Yes | No | Drug treatment | Surgical treatment | |||||||
T2DM group | 230 | 90 (39.1) | 140 (60.9) | 42 (18.3) | 188 (81.7) | 42 (18.3) | 188 (81.7) | 13.15±9.51 | 78 (33.9) | 152 (66.1) | 84 (36.5) | 78 (33.9) | 66 (28.7) | 2 (0.9) |
NDM group | 168 | 80 (47.6) | 88 (52.4) | 38 (22.6) | 130 (77.4) | 41 (24.4) | 127 (75.6) | 10.67±6.23 | 85 (50.6) | 83 (49.4) | 45 (26.8) | 43 (25.6) | 77 (45.8) | 3 (1.8) |
t/χ2 | 2.859 | 1.148 | 2.220 | -3.131 | 13.733 | 4.201 | 3.174 | 12.386 | ||||||
P | >0.05 | >0.05 | >0.05 | <0.01 | <0.01 | <0.05 | >0.05 | <0.001 | >0.05a |
AK: Acanthamoeba keratitis; aFisher precise test.
mean±SD, n (%)